Insider Transactions in Q4 2025 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2025
|
Thomas Cusack |
BUY
Grant, award, or other acquisition
|
Direct |
37,879
+50.0%
|
-
|
|
Oct 31
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,694
+6.57%
|
-
|
|
Oct 31
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,789
+6.24%
|
-
|
|
Oct 31
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,694
+6.11%
|
-
|
|
Oct 19
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+2.45%
|
-
|
|
Oct 19
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+2.25%
|
-
|
|
Oct 19
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,797
+2.75%
|
-
|
|
Oct 15
2025
|
Rubric Capital Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
946,100
+3.05%
|
-
|